
Remote Patient Monitoring Market - Global Outlook & Forecast 2022-2027
Description
Remote Patient Monitoring Market - Global Outlook & Forecast 2022-2027
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Remote Patient Monitoring Market Report
The global remote patient monitoring market to grow at a CAGR of 12.5% during 2021-2027.
Remote patient monitoring is achieved by using digital technologies to monitor and capture medical health-related data from patients and electronically transmit the information to healthcare providers for assessment, and, when necessary, recommendations and instructions are provided. RPM reduces the number of readmissions in the medical requirement, hospitalizations, and duration of stay in the hospital, which leads to improved quality of life and contain costs.
In August 2020, Stasis Labs introduced a mobile-connected remote patient monitoring technology in hospitals and outpatient settings in the US. The company's Stasis system monitors important vital parameters in its functioning.
In July 2020, Philips and BioIntelliSense teamed together to improve remote patient monitoring systems for at-risk patients from the hospital to their homes. Philips has added the BioIntelliSense sensor to the device for remotely usage.
REMOTE PATIENT MONITORING MARKET SEGMENT
The Devices and Software segment accounted for the largest share in the global remote patient monitoring market. With the emergence of connected cardiac implants, cardiology was one of the first specialties to incorporate RPM. Cardiology practices are now particularly well-positioned to gain the short and long-term benefits associated with the progression of RPM services, technology, and regulation. The cardiac monitoring market is further propelled by innovative product characteristics, as well as the increased need and demand for virtual care solutions in the COVID-19 era. The cardiac monitor segment accounted for the maximum share in the remote patient monitoring market. For instance, according to CDC, 30.3 million US adults were identified with heart disorders in 2018. Thus, the high prevalence of cardiac disorder is expected to drive the segment.
Component:
Cardiac monitors
Blood Pressure Monitor
Others
Pulse Oximeters
Others
North America accounted for a significant 40% of the global market for remote patient monitoring market share in 2021. The presence of substantial competitors and their growth strategies are the main factors driving the North American market. The industry is driven by rising healthcare spending and increased awareness about the benefits of sickness prevention. An increase in heart ailments, sedentary lifestyles, and the deployment of e-health in some rural areas of North America is expected to drive the market growth.
Geography
With many top companies in the global market and several small players in regional markets, the global remote patient monitoring market is somewhat fragmented. The major competitors in the market are focusing their efforts on reducing the size of the remote patient monitoring market. These companies are also attempting to increase their market share by launching new goods and forming collaborations with other market participants. As a result, these factors are expected to propel the remote patient monitoring market growth.
Top Players
1. The analysis of the global Remote Patient Monitoring market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Remote Patient Monitoring market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the Remote Patient Monitoring market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Remote Patient Monitoring Market Report
The global remote patient monitoring market to grow at a CAGR of 12.5% during 2021-2027.
Remote patient monitoring is achieved by using digital technologies to monitor and capture medical health-related data from patients and electronically transmit the information to healthcare providers for assessment, and, when necessary, recommendations and instructions are provided. RPM reduces the number of readmissions in the medical requirement, hospitalizations, and duration of stay in the hospital, which leads to improved quality of life and contain costs.
In August 2020, Stasis Labs introduced a mobile-connected remote patient monitoring technology in hospitals and outpatient settings in the US. The company's Stasis system monitors important vital parameters in its functioning.
In July 2020, Philips and BioIntelliSense teamed together to improve remote patient monitoring systems for at-risk patients from the hospital to their homes. Philips has added the BioIntelliSense sensor to the device for remotely usage.
REMOTE PATIENT MONITORING MARKET SEGMENT
The Devices and Software segment accounted for the largest share in the global remote patient monitoring market. With the emergence of connected cardiac implants, cardiology was one of the first specialties to incorporate RPM. Cardiology practices are now particularly well-positioned to gain the short and long-term benefits associated with the progression of RPM services, technology, and regulation. The cardiac monitoring market is further propelled by innovative product characteristics, as well as the increased need and demand for virtual care solutions in the COVID-19 era. The cardiac monitor segment accounted for the maximum share in the remote patient monitoring market. For instance, according to CDC, 30.3 million US adults were identified with heart disorders in 2018. Thus, the high prevalence of cardiac disorder is expected to drive the segment.
Component:
- Devices and Software
- Cardiac Monitoring Devices
Cardiac monitors
Blood Pressure Monitor
Others
- Respiratory Monitoring Devices
Pulse Oximeters
Others
- Blood Glucose Monitors
- Fetal & neonatal monitoring devices
- Other RPM
- Service
- Cardiology
- Endocrinology
- Pulmonology
- Others
- Hospitals & Specialty Clinics
- Home Care Settings
- Ambulatory Surgical Centers
- Long-term & Acute Care Centers
- Other
North America accounted for a significant 40% of the global market for remote patient monitoring market share in 2021. The presence of substantial competitors and their growth strategies are the main factors driving the North American market. The industry is driven by rising healthcare spending and increased awareness about the benefits of sickness prevention. An increase in heart ailments, sedentary lifestyles, and the deployment of e-health in some rural areas of North America is expected to drive the market growth.
Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- France
- Spain
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- Turkey
- Saudi Arabia
- South Africa
With many top companies in the global market and several small players in regional markets, the global remote patient monitoring market is somewhat fragmented. The major competitors in the market are focusing their efforts on reducing the size of the remote patient monitoring market. These companies are also attempting to increase their market share by launching new goods and forming collaborations with other market participants. As a result, these factors are expected to propel the remote patient monitoring market growth.
Top Players
- Medtronic
- Philips Healthcare
- ResMed
- Resideo
- Honeywell
- LST (LifeScience Technologies)
- Coforge
- Withings
- MedM
- iHealthUnifiedcare
- Qardio
- 100-Plus
- A&D
- Abbott
- AltumView Systems
- Biotronik
- Boston Scientific
- Bardy Diagnostics
- Cardiomo
- Cardiologs
- Dragerwerk AG
- Hoffmann-La Roche
- GE Healthcare
- GrandCare
- Masimo Corporation
- Medopad
- Nihon Kohden
- Omron Healthcare
- OSPLabs
- Smiths Medical
- Spacelabs
- Senseonics
- TeleMedCare
- VitalConnect
- Vitls
- Modicare
- Hillrom
- Vivify Health
- ACL Digital
- Dexcom
- iRhythm Technologies
- Vivalink
- Biobeat
- CareValidate
- Biofourmis
- CAREMINDr
- Datos Health
1. The analysis of the global Remote Patient Monitoring market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Remote Patient Monitoring market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the Remote Patient Monitoring market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
Table of Contents
335 Pages
- 1 RESEARCH METHODOLOGY
- 2 RESEARCH OBJECTIVES
- 3 RESEARCH PROCESS
- 4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY COMPONENT
- 4.3.2 MARKET SEGMENTATION BY APPLICATION
- 4.3.3 MARKET SEGMENTATION BY END-USER
- 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
- 5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
- 6 MARKET AT A GLANCE
- 7 INTRODUCTION
- 7.1 OVERVIEW
- 7.1.1 COVID-19 IMPACT ON REMOTE PATIENT MONITORING MARKET
- 8 MARKET OPPORTUNITIES & TRENDS
- 8.1 INCREASING ROLE OF IOT IN REMOTE MONITORING & HEALTHCARE APPLICATIONS
- 8.2 PARADIGM SHIFT TOWARD HOME-BASED HEALTHCARE DEVICES
- 8.3 TELEMEDICINE USHERING NEW OPPORTUNITIES IN REMOTE MONITORING
- 9 MARKET GROWTH ENABLERS
- 9.1 AGING POPULATION VULNERABLE TO CHRONIC DISEASES
- 9.2 RISING WEARABLE MEDICAL TECHNOLOGY INNOVATIONS
- 9.3 GROWING USE OF RPM TO PROACTIVELY MONITOR & IMPROVE PATIENT ENGAGEMENT
- 9.4 INCREASED DEMAND FOR REMOTE MONITORING DUE TO COVID-19
- 10 MARKET GROWTH RESTRAINTS
- 10.1 LOW AWARENESS OF REMOTE MONITORING IN DEVELOPING COUNTRIES
- 10.2 LACK OF DATA ACCURACY
- 11 MARKET LANDSCAPE
- 11.1 MARKET OVERVIEW
- 11.2 MARKET SIZE & FORECAST
- 11.2.1 MARKET SHARE BY COMPONENT
- 11.2.2 MARKET SHARE BY DEVICES & SOFTWARE
- 11.2.3 MARKET SHARE BY APPLICATION
- 11.2.4 MARKET SHARE BY END-USER
- 11.2.5 MARKET BY GEOGRAPHY
- 11.3 FIVE FORCES ANALYSIS
- 11.3.1 THREAT OF NEW ENTRANTS
- 11.3.2 BARGAINING POWER OF SUPPLIERS
- 11.3.3 BARGAINING POWER OF BUYERS
- 11.3.4 THREAT OF SUBSTITUTES
- 11.3.5 COMPETITIVE RIVALRY
- 12 COMPONENT
- 12.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13 DEVICES & SOFTWARE
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 CARDIAC MONITORING DEVICES
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 CARDIAC MONITORING DEVICES: MARKET BY GEOGRAPHY
- 13.4 ELECTROCARDIOGRAPHS (ECGS)
- 13.4.1 MARKET OVERVIEW
- 13.4.2 ELECTROCARDIOGRAM (ECG): MARKET SIZE & FORECAST
- 13.5 CARDIAC MONITORS
- 13.5.1 MARKET OVERVIEW
- 13.5.2 CARDIAC MONITORS: MARKET SIZE & FORECAST
- 13.6 BLOOD PRESSURE MONITORS
- 13.6.1 MARKET OVERVIEW
- 13.6.2 MARKET SIZE & FORECAST
- 13.7 OTHER CARDIAC MONITORING DEVICES
- 13.7.1 MARKET OVERVIEW
- 13.7.2 MARKET SIZE & FORECAST
- 13.8 RESPIRATORY MONITORING DEVICES
- 13.8.1 MARKET OVERVIEW
- 13.8.2 MARKET SIZE & FORECAST
- 13.8.3 RESPIRATORY MONITORING DEVICES: MARKET BY GEOGRAPHY
- 13.9 APNEA MONITORS
- 13.9.1 MARKET OVERVIEW
- 13.9.2 MARKET SIZE & FORECAST
- 13.10 PULSE OXIMETERS
- 13.10.1 MARKET OVERVIEW
- 13.10.2 MARKET SIZE & FORECAST
- 13.11 OTHER RESPIRATORY MONITORING DEVICES
- 13.11.1 MARKET OVERVIEW
- 13.11.2 MARKET SIZE & FORECAST
- 13.12 BLOOD GLUCOSE MONITORS
- 13.12.1 MARKET OVERVIEW
- 13.12.2 MARKET SIZE & FORECAST
- 13.12.3 BLOOD GLUCOSE MONITORS: MARKET BY GEOGRAPHY
- 13.13 FETAL & NEONATAL MONITORING DEVICES
- 13.13.1 MARKET OVERVIEW
- 13.13.2 MARKET SIZE & FORECAST
- 13.13.3 FETAL & NEONATAL MONITORING DEVICES: MARKET BY GEOGRAPHY
- 13.14 OTHER RPM DEVICES
- 13.14.1 MARKET OVERVIEW
- 13.14.2 MARKET SIZE & FORECAST
- 13.14.3 OTHER RPM DEVICES: MARKET BY GEOGRAPHY
- 13.15 SERVICES
- 13.15.1 MARKET OVERVIEW
- 13.15.2 MARKET SIZE & FORECAST
- 13.15.3 REMOTE PATIENT MONITORING SERVICES: MARKET BY GEOGRAPHY
- 14 APPLICATION
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 CARDIOLOGY
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 CARDIOLOGY REMOTE PATIENT MONITORING: MARKET BY GEOGRAPHY
- 14.4 PULMONOLOGY
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 PULMONOLOGY REMOTE PATIENT MONITORING: MARKET BY GEOGRAPHY
- 14.5 ENDOCRINOLOGY
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 REMOTE ENDOCRINOLOGY PATIENT MONITORING: MARKET BY GEOGRAPHY
- 14.6 OTHERS
- 14.6.1 MARKET OVERVIEW
- 14.6.2 MARKET SIZE & FORECAST
- 14.6.3 OTHER: MARKET BY GEOGRAPHY
- 15 END-USER
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 MARKET OVERVIEW
- 15.3 HOSPITALS & SPECIALTY CLINICS
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 HOSPITALS & SPECIALTY CLINICS: MARKET BY GEOGRAPHY
- 15.4 HOMECARE SETTINGS
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 HOMECARE SETTINGS: MARKET BY GEOGRAPHY
- 15.5 AMBULATORY SURGICAL CENTERS
- 15.5.1 MARKET OVERVIEW
- 15.5.2 MARKET SIZE & FORECAST
- 15.5.3 AMBULATORY SURGICAL CENTERS: MARKET BY GEOGRAPHY
- 15.6 LONG-TERM & ACUTE CARE CENTERS
- 15.6.1 MARKET OVERVIEW
- 15.6.2 MARKET SIZE & FORECAST
- 15.6.3 LONG-TERM & ACUTE CARE CENTERS: MARKET BY GEOGRAPHY
- 15.7 OTHERS
- 15.7.1 MARKET OVERVIEW
- 15.7.2 MARKET SIZE & FORECAST
- 15.7.3 OTHERS: MARKET BY GEOGRAPHY
- 16 GEOGRAPHY
- 16.1 MARKET SNAPSHOT & GROWTH ENGINE
- 16.2 GEOGRAPHIC OVERVIEW
- 17 NORTH AMERICA
- 17.1 MARKET OVERVIEW
- 17.2 MARKET SIZE & FORECAST
- 17.3 NORTH AMERICA: COMPONENT SEGMENTATION (REVENUE)
- 17.4 NORTH AMERICA: APPLICATION SEGMENTATION (REVENUE)
- 17.5 NORTH AMERICA: END-USER SEGMENTATION (REVENUE)
- 17.6 NORTH AMERICA: KEY COUNTRIES
- 17.6.1 US: MARKET SIZE & FORECAST
- 17.6.2 CANADA: MARKET SIZE & FORECAST
- 18 EUROPE
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 EUROPE: COMPONENT SEGMENTATION (REVENUE)
- 18.4 EUROPE: APPLICATION SEGMENTATION (REVENUE)
- 18.5 EUROPE: END-USER SEGMENTATION (REVENUE)
- 18.7 EUROPE: KEY COUNTRIES
- 18.7.1 GERMANY: MARKET SIZE & FORECAST
- 18.7.2 UK: MARKET SIZE & FORECAST
- 18.7.3 FRANCE: MARKET SIZE & FORECAST
- 18.7.4 SPAIN: MARKET SIZE & FORECAST
- 18.7.5 ITALY: MARKET SIZE & FORECAST
- 19 APAC
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 APAC: COMPONENT SEGMENTATION (REVENUE)
- 19.4 APAC: APPLICATION SEGMENTATION (REVENUE)
- 19.5 APAC: END-USER SEGMENTATION (REVENUE)
- 19.6 APAC: KEY COUNTRIES
- 19.6.1 CHINA: MARKET SIZE & FORECAST
- 19.6.2 JAPAN: MARKET SIZE & FORECAST
- 19.6.3 INDIA: MARKET SIZE & FORECAST
- 19.6.4 AUSTRALIA: MARKET SIZE & FORECAST
- 19.6.5 SOUTH KOREA: MARKET SIZE & FORECAST
- 20 LATIN AMERICA
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 LATIN AMERICA: COMPONENT SEGMENTATION (REVENUE)
- 20.4 LATIN AMERICA: APPLICATION SEGMENTATION (REVENUE)
- 20.5 LATIN AMERICA: END-USER SEGMENTATION (REVENUE)
- 20.6 LATIN AMERICA: KEY COUNTRIES
- 20.6.1 MEXICO: MARKET SIZE & FORECAST
- 20.6.2 ARGENTINA: MARKET SIZE & FORECAST
- 20.6.3 BRAZIL: MARKET SIZE & FORECAST
- 21 MIDDLE EAST & AFRICA
- 21.1 MARKET OVERVIEW
- 21.2 MARKET SIZE & FORECAST
- 21.3 MIDDLE EAST & AFRICA: COMPONENT SEGMENTATION (REVENUE)
- 21.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION (REVENUE)
- 21.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION (REVENUE)
- 21.6 MIDDLE EAST & AFRICA: KEY COUNTRIES
- 21.6.1 TURKEY: MARKET SIZE & FORECAST
- 21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
- 21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
- 22 COMPETITIVE LANDSCAPE
- 22.1 MARKET SHARE ANALYSIS
- 22.1.1 MEDTRONIC
- 22.1.2 PHILIPS HEALTHCARE
- 22.1.3 RESMED
- 22.2 MARKET SHARE ANALYSIS OVERVIEW BY SERVICES
- 22.2.1 WITHINGS
- 22.2.2 MEDM
- 22.2.3 IHEALTHUNIFIEDCARE
- 22.2.4 QARDIO
- 23 KEY VENDORS
- 23.1 MEDTRONIC
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 PRODUCT OFFERING
- 23.2 PHILIPS HEALTHCARE
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERING
- 23.3 RESMED
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERING
- 24 OTHER PROMINENT VENDORS
- 24.1 RESIDEO TECHNOLOGIES
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERING
- 24.2 HONEYWELL INTERNATIONAL
- 24.2.1 BUSINESS OVERVIEW
- 24.3 LIFESCIENCE TECHNOLOGIES
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERING
- 24.4 COFORGE
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERING
- 24.5 WITHINGS
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 PRODUCT OFFERING
- 24.6 MEDM
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 PRODUCT OFFERING
- 24.7 IHEALTHUNIFIEDCARE
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 PRODUCT OFFERINGS
- 24.8 QARDIO
- 24.8.1 BUSINESS OVERVIEW
- 24.8.2 PRODUCT OFFERINGS
- 24.9 100-PLUS
- 24.9.1 BUSINESS OVERVIEW
- 24.9.2 PRODUCT OFFERINGS
- 24.10 A&D COMPANY
- 24.10.1 BUSINESS OVERVIEW
- 24.10.2 PRODUCT OFFERINGS
- 24.11 ABBOTT
- 24.11.1 BUSINESS OVERVIEW
- 24.11.2 PRODUCT OFFERINGS
- 24.12 ALTUMVIEW SYSTEMS
- 24.12.1 BUSINESS OVERVIEW
- 24.12.2 PRODUCT OFFERINGS
- 24.13 BIOTRONIK
- 24.13.1 BUSINESS OVERVIEW
- 24.13.2 PRODUCT OFFERING
- 24.14 BOSTON SCIENTIFIC
- 24.14.1 BUSINESS OVERVIEW
- 24.14.2 PRODUCT OFFERINGS
- 24.15 BARDY DIAGNOSTICS
- 24.15.1 BUSINESS OVERVIEW
- 24.15.2 PRODUCT OFFERINGS
- 24.16 CARDIOMO CARE
- 24.16.1 BUSINESS OVERVIEW
- 24.16.2 PRODUCT OFFERINGS
- 24.17 CARDIOLOGS
- 24.17.1 BUSINESS OVERVIEW
- 24.17.2 PRODUCT OFFERINGS
- 24.18 DRAGERWERK AG
- 24.18.1 BUSINESS OVERVIEW
- 24.18.2 PRODUCT OFFERINGS
- 24.19 F. HOFFMANN-LA ROCHE
- 24.19.1 BUSINESS OVERVIEW
- 24.19.2 PRODUCT OFFERINGS
- 24.20 GE HEALTHCARE
- 24.20.1 BUSINESS OVERVIEW
- 24.20.2 PRODUCT OFFERINGS
- 24.21 GRANDCARE SYSTEMS
- 24.21.1 BUSINESS OVERVIEW
- 24.21.2 PRODUCT OFFERINGS
- 24.22 MASIMO CORPORATION
- 24.22.1 BUSINESS OVERVIEW
- 24.22.2 PRODUCT OFFERINGS
- 24.23 MEDOPAD
- 24.23.1 BUSINESS OVERVIEW
- 24.23.2 PRODUCT OFFERINGS
- 24.24 NIHON KOHDEN
- 24.24.1 BUSINESS OVERVIEW
- 24.24.2 PRODUCT OFFERINGS
- 24.25 OMRON HEALTHCARE
- 24.25.1 BUSINESS OVERVIEW
- 24.25.2 PRODUCT OFFERINGS
- 24.26 OSPLABS
- 24.26.1 BUSINESS OVERVIEW
- 24.26.2 PRODUCT OFFERINGS
- 24.27 SMITHS MEDICAL
- 24.27.1 BUSINESS OVERVIEW
- 24.27.2 PRODUCT OFFERINGS
- 24.28 SPACELABS HEALTHCARE
- 24.28.1 BUSINESS OVERVIEW
- 24.28.2 PRODUCT OFFERINGS
- 24.29 SENSEONICS
- 24.29.1 BUSINESS OVERVIEW
- 24.29.2 PRODUCT OFFERINGS
- 24.30 TELEMEDCARE
- 24.30.1 BUSINESS OVERVIEW
- 24.30.2 PRODUCT OFFERINGS
- 24.31 VITALCONNECT
- 24.31.1 BUSINESS OVERVIEW
- 24.31.2 PRODUCT OFFERINGS
- 24.32 VITLS
- 24.32.1 BUSINESS OVERVIEW
- 24.32.2 PRODUCT OFFERINGS
- 24.33 MODICARE
- 24.33.1 BUSINESS OVERVIEW
- 24.33.2 PRODUCT OFFERINGS
- 24.34 HILLROM
- 24.34.1 BUSINESS OVERVIEW
- 24.34.2 PRODUCT OFFERINGS
- 24.35 VIVIFY HEALTH
- 24.35.1 BUSINESS OVERVIEW
- 24.35.2 PRODUCT OFFERING
- 24.36 ACL DIGITAL
- 24.36.1 BUSINESS OVERVIEW
- 24.36.2 PRODUCT OFFERINGS
- 24.37 DEXCOM
- 24.37.1 BUSINESS OVERVIEW
- 24.37.2 PRODUCT OFFERING
- 24.38 IRHYTHM TECHNOLOGIES
- 24.38.1 BUSINESS OVERVIEW
- 24.38.2 PRODUCT OFFERING
- 24.39 VIVALINK
- 24.39.1 BUSINESS OVERVIEW
- 24.39.2 PRODUCT OFFERING
- 24.40 BIOBEAT
- 24.40.1 BUSINESS OVERVIEW
- 24.40.2 PRODUCT OFFERINGS
- 24.41 CAREVALIDATE
- 24.41.1 BUSINESS OVERVIEW
- 24.41.2 PRODUCT OFFERINGS
- 24.42 BIOFOURMIS
- 24.42.1 BUSINESS OVERVIEW
- 24.42.2 PRODUCT OFFERING
- 24.43 CAREMINDR
- 24.43.1 BUSINESS OVERVIEW
- 24.43.2 PRODUCT OFFERING
- 24.44 DATOS HEALTH
- 24.44.1 BUSINESS OVERVIEW
- 24.44.2 PRODUCT OFFERINGS
- 25 REPORT SUMMARY
- 25.1 KEY TAKEAWAYS
- 25.2 STRATEGIC RECOMMENDATIONS
- 26 QUANTITATIVE SUMMARY
- 26.1 MARKET BY GEOGRAPHY
- 26.2 MARKET BY COMPONENTS
- 26.2.1 MARKET BY DEVICES & SOFTWARE
- 26.2.2 MARKET BY CARDIAC MONITORING DEVICES
- 26.2.3 MARKET BY RESPIRATORY MONITORING DEVICES
- 26.3 MARKET BY APPLICATION
- 26.4 MARKET BY END-USER
- 26.5 NORTH AMERICA: BY COMPONENTS
- 26.5.1 DEVICES & SOFTWARE
- 26.5.2 CARDIAC MONITORING DEVICES
- 26.5.3 RESPIRATORY MONITORING DEVICES
- 26.6 NORTH AMERICA: BY APPLICATION
- 26.7 NORTH AMERICA: BY END-USER
- 26.8 EUROPE: BY COMPONENTS
- 26.8.1 DEVICES & SOFTWARE
- 26.8.2 CARDIAC MONITORING DEVICES
- 26.8.3 RESPIRATORY MONITORING DEVICES
- 26.9 EUROPE: BY APPLICATION
- 26.10 EUROPE: BY END-USER
- 26.11 APAC: BY COMPONENTS
- 26.11.1 DEVICES & SOFTWARE
- 26.11.2 CARDIAC MONITORING DEVICES
- 26.11.3 RESPIRATORY MONITORING DEVICES
- 26.12 APAC: BY APPLICATION
- 26.13 APAC: BY END-USER
- 26.14 LATIN AMERICA: BY COMPONENTS
- 26.14.1 DEVICES & SOFTWARE
- 26.14.2 CARDIAC MONITORING DEVICES
- 26.14.3 RESPIRATORY MONITORING DEVICES
- 26.15 LATIN AMERICA: BY APPLICATION
- 26.16 LATIN AMERICA: BY END-USER
- 26.17 MIDDLE EAST & AFRICA: BY COMPONENTS
- 26.17.1 DEVICES & SOFTWARE
- 26.17.2 CARDIAC MONITORING DEVICES
- 26.17.3 RESPIRATORY MONITORING DEVICES
- 26.18 MIDDLE EAST & AFRICA: BY APPLICATION
- 26.19 MIDDLE EAST & AFRICA: BY END-USER
- 27 APPENDIX
- 27.1 ABBREVIATIONS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.